Finance

Lists
Why is BIAF down 4.02%?
Dive Deeper
BIAF:NASDAQ
bioAffinity Technologies Inc
$3.58
-4.02%
(-0.15) 1D
Oct 19, 11:26:14 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BIAF...
Open
$3.67
High
$3.69
Low
$3.52
Mkt. cap
4.59M
Avg. vol.
3.76M
Volume
19.56K
52-wk high
$80.70
52-wk low
$3.23
EPS
-$103.35
Beta
-1.25
Shares outstanding
1.28M
No. of employees
57
Open
$3.67
High
$3.69
Low
$3.52
Mkt. cap
4.59M
Avg. vol.
3.76M
Volume
19.56K
52-wk high
$80.70
52-wk low
$3.23
EPS
-$103.35
Beta
-1.25
Shares outstanding
1.28M
No. of employees
57
News stories
From web sources and news partners
About bioAffinity Technologies Inc
CEO-
Employees57
Founded2014
HeadquartersSan Antonio, Texas, United States
SectorBiotechnology
Website-
Analyst
Recommendation
Action
Price target
Projected
Date
Anthony Vendetti
Maxim Group
Buy
Maintained
-
-
11/18/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.45M
1.59M
1.35M
1.51M
Cost of goods sold
942.21K
900.13K
928.64K
1.09M
Cost of revenue
942.21K
900.13K
928.64K
1.09M
Research and development expenses
473.90K
668.81K
683.75K
837.46K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.21M
3.04M
3.24M
2.86M
Operating expense
2.80M
3.83M
4.04M
3.76M
Total operating expenses
3.74M
4.73M
4.97M
4.85M
Operating income
-2.29M
-3.14M
-3.62M
-3.33M
Other non operating income
-2.75M
-3.98K
-8.94K
-22.89K
EBT including unusual items
-5.05M
-3.13M
-3.63M
-3.37M
EBT excluding unusual items
-5.05M
-3.13M
-3.63M
-3.37M
Income tax expense
3.18K
3.18K
-
-
Effective tax rate
-0.06%
-0.10%
-
-
Other operating expenses
-
-
-
-
Net income
-5.05M
-3.14M
-3.63M
-3.37M
Net profit margin
-349.30%
-196.98%
-268.63%
-222.83%
Earnings per share
-71.10
-
-
-
Interest and investment income
1.09K
19.73K
10.03K
3.36K
Interest expense
-5.36K
-13.07K
-14.72K
-11.69K
Net interest expenses
-4.27K
6.66K
-4.70K
-8.33K
Depreciation and amortization charges
113.36K
123.66K
114.52K
61.56K
EBITDA
-2.18M
-3.01M
-3.50M
-3.27M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps